Clinical Medicine Insights: Women's Health 2013:6 37-49
Review
Published on 06 May 2013
DOI: 10.4137/CMWH.S8015
Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Women's Health
The objective of this review was to evaluate the clinical efficacy and safety of remifentanil in the management of labor pain. Although neuraxial analgesia is the best option during labor, alternative analgesic options are needed for patients with contraindications. Using a systematic literature search, clinical outcomes of remifentanil for labor pain have been summarized. Also, comparisons of remifentanil to other options including meperidine, epidural analgesia, fentanyl, and nitrous oxide are provided. Based on the literature review, remifentanil is associated with high overall maternal satisfaction and favorable side-effect profile. However, due to the low reporting of adverse events, large, randomized controlled trials are needed to evaluate maternal and neonatal safety adequately and determine the optimal dosing needed to provide effective analgesia. While remifentanil is a feasible alternative for patients who cannot or do not want to receive epidural analgesia, administration should be monitored closely for potential adverse effects.
PDF (556.32 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
PMC HTML
Clinical Medicine Insights: Cardiology is very much conscious of time. Every step is done thoroughly and rapidly. The reviewers' comments are constructive. There is regular contact with the authors, providing explanations where necessary. The visibility also enjoyed by one's article once it is published is worthy of note. Thanks for making publishing with you so easy and enjoyable.
Facebook Google+ Twitter
Pinterest Tumblr YouTube